價(jià)格 | 詢(xún)價(jià) | ||
包裝 | 1支 | 1支 | 1支 |
最小起訂量 | 1支 |
發(fā)貨地 | 湖北 |
更新日期 | 2025-01-24 |
中文名稱(chēng):拉貝珠單抗 | 英文名稱(chēng):Research Grade Labetuzumab(DHC21001) |
CAS:219649-07-7 | 純度規(guī)格: PAGE:>95% |
產(chǎn)品類(lèi)別: 藥物對(duì)照抗體 | |
抗體名: labetuzumab | 靶點(diǎn): Meconium antigen 100, CEACAM5, CEA, CD66e, Carcinoembryonic antigen-related cell adhesion molecule 5, Carcinoembryonic antigen |
宿主: Humanized | 適應(yīng)物種: Human |
克隆性: Monoclonal | 藥物對(duì)照抗體: labetuzumab |
Tags:labetuzumab 代理商,labetuzumab 價(jià)格,labetuzumab 供應(yīng)商, labetuzumab supplier,labetuzumab purchase,labetuzumab 購(gòu)買(mǎi),labetuzumab 銷(xiāo)售
Catalog No.
DHC21001
Host species
Humanized
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95%
Clonality
Monoclonal
Isotype
IgG1-kappa
Applications
Research Grade Biosimilar
Target
Meconium antigen 100, CEACAM5, CEA, CD66e, Carcinoembryonic antigen-related cell adhesion molecule 5, Carcinoembryonic antigen
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
P06731
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
hMN14, IMMU-130, hMN-14-SN-38, hMN-14-SN-38 ADC, hMN14-CL-SN-38, Labetuzumab Govitecan, CAS: 219649-07-7
Note
For research use only. Not suitable for clinical or therapeutic use.
成立日期 | 2021-04-08 (4年) | 注冊(cè)資本 | 700萬(wàn) |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1000萬(wàn)-5000萬(wàn) |
主營(yíng)行業(yè) | 生物化工,技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 試劑 |
產(chǎn)品名稱(chēng) | 價(jià)格 | 公司名稱(chēng) | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥3850 |
VIP3年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2025-01-22 | |
詢(xún)價(jià) |
VIP4年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2025-01-23 | |
詢(xún)價(jià) |
卡梅德生物科技(天津)有限公司
|
2024-08-30 | ||
¥2980 |
VIP3年
|
TargetMol中國(guó)(陶術(shù)生物)
|
2024-12-12 |